MALAT1 down-regulation by siRNA inhibits prostate cancer cell growth, invasion and migration49; NEAT1 drives prostate cancer growth by altering the epigenetic landscape of target gene promoters to favor transcription50; and LINC00963 is involved in the transition of prostate cancer from androgen dependent to androgen independent51. Here, MALAT1 is linked to prostate carcinoma.